Former NBA player Al Harrington wants to get in on the marijuana industry. And it all started, surprisingly, with his grandma.
“She suffered from glaucoma and diabetes...I was reading about all the medicinal benefits of cannabis, and I said that she should try it,” Harrington told Cheddar.
Initially his grandmother resisted, but after her very first try she was already feeling a lot better. “She inspired me to invest in a company to get into the cannabis space.”
Later this year, Harrington will release his own line of marijuana products aimed at pain relief for athletes, one he created by drawing on his own experiences. He had 14 surgeries throughout his career and told Cheddar that he suffered from chronic pain.
In the next three to five years, the NBA may even remove marijuana from its list of banned substances for players, starting with CBD products, says Harrington.
“Players should have access to...an alternative way of medicating themselves.”
“I’m a firm believer that if I had known this information that I know now, I probably could have played another three years in the NBA,” says Harrington.
Harrington spent 16 years in the league, most recently with the Washington Wizards, before retiring from the Sydney Kings in 2015.
For the full interview, [click here](https://cheddar.com/videos/how-former-nba-star-al-harrington-is-capitalizing-on-cannabis).
Jared Smith, sports betting analyst from Pickswise, joins Cheddar Bets to break down the biggest games of the college football weekend, including those that put Ohio State and Oregon's Playoff spots on the line.
Sponsored by BetMGM
Cognitive healthcare platform BrainCheck recently raised $10 million in a Series B round. The platform offers neurologists a new way to detect and care for brain disorders like Alzeheimer's, and brain injuries like concussions. BrainCheck CEO Yael Katz joined Cheddar News' Closing Bell to discuss.
Three-time Grammy Award winner Darius Rucker joins Cheddar News to discuss his new apparel line, NFL x Darius Rucker Collection by Fanatics, a new line of officially licensed NFL apparel inspired by Rucker’s love of music, football, and fashion.
Jill Wagner is joined by Baker to talk about kids and vaccines: we finally know how many young kids are getting vaccinated. Plus, Democrats are working on a Plan B for paid family leave. And the salad chain Sweetgreen goes public.
Beginning Christmas Day, the home of the Los Angeles Lakers, Clippers, Kings, and Sparks, the Staples Center, will go by the name Crypto.com Arena after a massive $700 million deal with AEG. Steven Kalifowitz, the chief marketing officer at Crypto.com, and Todd Goldstein, the chief revenue officer at AEG, joined Cheddar to talk about the historic changeover in naming rights and what other changes that fans entering the arena might expect.
The iconic Los Angeles Staples Center will sport a new moniker, Crypto.com Arena, beginning Christmas Day. AEG made the naming-rights deal with Crypto for a historic $700 million.
Jill is joined by “Friend of the Pod” Mosheh Oinounou to talk booster shots, and whether “fully vaccinated” will eventually mean three shots, not two. Plus, the latest on the Kyle Rittenhouse trial. And the research is in: we know now the perfect way to hug. Also, Jill and Mosheh debate whether Airpods are passé.
The Green Bay Packers are selling shares of their stock for just the sixth time in its 102-year history. The Packers are the only major professional sports team in the U.S. that is publicly owned and not-for-profit. Now, it is offering 300,000 shares at $300 apiece; however, fans who become shareholders will not have much power, as the Packers' stock is not technically a stock. Washington Post sports reporter Des Bieler joins Cheddar News' Closing Bell to discuss.
Jill is joined by Baker Machado to talk all things infrastructure: where will the money go and who’s in charge? Plus, Sesame Street has its first Asian-American muppet. And a trailer for the trailer for Spiderman. Huh?
